MeSH term
Frequency | Condition_Probility | Animals | 39 | 0.0 |
COS Cells | 9 | 0.0 |
Cell Line | 20 | 0.0 |
Chromatin/metabolism | 6 | 2.0 |
Genes, Reporter | 9 | 0.0 |
Glutathione Transferase/genetics | 2 | 0.0 |
Hela Cells | 29 | 0.0 |
Humans | 86 | 0.0 |
Macromolecular Substances | 8 | 0.0 |
Mammary Tumor Virus, Mouse/genetics | 2 | 5.0 |
Molecular Sequence Data | 20 | 0.0 |
Precipitin Tests | 11 | 0.0 |
Promoter Regions (Genetics)/genetics/physiology | 2 | 10.0 |
Protein Structure, Tertiary/physiology | 2 | 1.0 |
Rats | 2 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 9 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 47 | 0.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Transfection | 19 | 0.0 |
Acetylation | 35 | 6.0 |
Acetyltransferases/*antagonists & inhibitors | 2 | 66.0 |
Cells, Cultured | 6 | 0.0 |
DNA Damage | 3 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Promoter Regions (Genetics) | 12 | 0.0 |
Protein p53/*metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 54 | 0.0 |
Transcription, Genetic | 16 | 0.0 |
Acetyltransferases/chemistry/*metabolism | 3 | 60.0 |
Blotting, Western | 9 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Luciferases/metabolism | 5 | 0.0 |
Lysine/chemistry | 3 | 3.0 |
Peptides/chemistry | 3 | 0.0 |
Plasmids/metabolism | 9 | 0.0 |
Protein Binding | 22 | 0.0 |
Protein Structure, Tertiary | 18 | 0.0 |
Recombinant Proteins/metabolism | 7 | 0.0 |
*Saccharomyces cerevisiae Proteins | 36 | 3.0 |
Trans-Activation (Genetics) | 11 | 0.0 |
*Transcription, Genetic | 9 | 0.0 |
Acetyltransferases/metabolism | 7 | 9.0 |
Down-Regulation | 2 | 0.0 |
Histones/*metabolism | 8 | 6.0 |
Amino Acid Sequence | 19 | 0.0 |
Binding Sites | 12 | 0.0 |
Models, Biological | 4 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
Signal Transduction | 4 | 0.0 |
HIV Long Terminal Repeat | 4 | 2.0 |
Models, Molecular | 4 | 0.0 |
Molecular Structure | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
3T3 Cells | 2 | 0.0 |
Mice | 19 | 0.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Nuclear Proteins/chemistry/*metabolism | 2 | 3.0 |
Trans-Activators/chemistry/*metabolism | 2 | 3.0 |
Acetyltransferases/*metabolism | 21 | 26.0 |
Adenovirus E1A Proteins/metabolism | 2 | 6.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Gene Expression Regulation | 5 | 0.0 |
Histones/metabolism | 12 | 5.0 |
TATA-Box Binding Protein | 2 | 0.0 |
Trans-Activators/*metabolism | 13 | 1.0 |
Transcription Factors/*metabolism | 6 | 0.0 |
Transcription, Genetic/*physiology | 2 | 1.0 |
Viral Proteins/metabolism | 2 | 2.0 |
Estrogen Receptor alpha | 2 | 0.0 |
Male | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Tumor Cells, Cultured | 12 | 0.0 |
DNA/metabolism | 7 | 0.0 |
Glutathione Transferase/metabolism | 7 | 0.0 |
*Repressor Proteins | 2 | 0.0 |
Trans-Activators/chemistry/metabolism | 2 | 13.0 |
Transcription Factors/metabolism | 8 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Acetyltransferases/genetics/*metabolism | 5 | 20.0 |
Nuclear Proteins/genetics/*metabolism | 5 | 1.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 6 | 0.0 |
Mutation | 10 | 0.0 |
Repressor Proteins/metabolism | 2 | 1.0 |
Cell Nucleus/metabolism | 7 | 0.0 |
Chromatin/*metabolism | 2 | 1.0 |
*DNA Damage | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 5 | 0.0 |
Nuclear Proteins/metabolism | 9 | 1.0 |
Nucleosomes/metabolism | 3 | 6.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
*Trans-Activation (Genetics) | 5 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
High Mobility Group Proteins/chemistry/*metabolism | 2 | 100.0 |
Lysine/metabolism | 5 | 7.0 |
Trans-Activators/metabolism | 8 | 0.0 |
Transcription Factors/chemistry/*metabolism | 2 | 1.0 |
DNA-Binding Proteins/genetics/*metabolism | 4 | 0.0 |
Histone Deacetylases/metabolism | 3 | 3.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Nuclear Proteins/genetics/metabolism | 4 | 2.0 |
Repressor Proteins/genetics/*metabolism | 2 | 1.0 |
Trans-Activators/genetics/metabolism | 3 | 1.0 |
Female | 2 | 0.0 |
Adenovirus E1A Proteins/metabolism/*physiology | 2 | 50.0 |
Apoptosis/*physiology | 2 | 0.0 |
Cell Division/*physiology | 2 | 1.0 |
Nuclear Proteins/*metabolism | 9 | 1.0 |
Recombinant Fusion Proteins/metabolism | 6 | 0.0 |
U937 Cells | 3 | 0.0 |
Substrate Specificity | 5 | 0.0 |
Acetyltransferases/chemistry/genetics/*metabolism | 2 | 66.0 |
Chromosome Mapping | 2 | 0.0 |
Protein Binding/genetics | 2 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Transcription, Genetic/physiology | 2 | 1.0 |
Carrier Proteins/*metabolism | 2 | 0.0 |
Cell Cycle Proteins/*metabolism | 8 | 2.0 |
Kinetics | 5 | 0.0 |
Receptors, Thyroid Hormone/*metabolism | 2 | 5.0 |
Trans-Activation (Genetics)/drug effects | 3 | 1.0 |
Protein Conformation | 3 | 0.0 |
Nuclear Localization Signal | 3 | 4.0 |
Trans-Activators/genetics/*metabolism | 5 | 1.0 |
Histones/chemistry/*metabolism | 2 | 18.0 |
Ligands | 2 | 0.0 |
Nuclear Proteins/*genetics | 3 | 0.0 |
Trans-Activators/*genetics | 2 | 0.0 |
Base Sequence | 6 | 0.0 |
Nucleosomes/*metabolism | 5 | 14.0 |
Catalysis | 2 | 0.0 |
Trans-Activation (Genetics)/genetics | 2 | 2.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Response Elements | 2 | 0.0 |
Gene Products, tat/genetics/*metabolism | 2 | 4.0 |
Trans-Activation (Genetics)/*physiology | 2 | 1.0 |
Acetyltransferases/*chemistry/metabolism | 2 | 66.0 |
Conserved Sequence | 2 | 0.0 |
*DNA-Binding Proteins | 4 | 0.0 |
Fungal Proteins/chemistry/metabolism | 2 | 16.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Phosphoproteins/genetics/*metabolism | 2 | 1.0 |
Repressor Proteins/genetics/metabolism | 2 | 2.0 |
Spodoptera | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Recombinant Proteins/chemistry/genetics/metabolism | 2 | 0.0 |
Cell Cycle Proteins/metabolism | 4 | 1.0 |
Phosphorylation | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Transcription, Genetic/*drug effects | 2 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Promoter Regions (Genetics)/genetics | 3 | 0.0 |
Chromatography, Affinity | 2 | 0.0 |
Chromatography, Gel | 3 | 0.0 |
Mutagenesis | 3 | 0.0 |
Comparative Study | 5 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Trans-Activators/*genetics/metabolism | 2 | 1.0 |
DNA/chemistry/metabolism | 2 | 2.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 2 | 0.0 |
Recombinant Proteins/chemistry | 2 | 0.0 |
Cell Cycle Proteins/genetics | 2 | 2.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Time Factors | 4 | 0.0 |
Ubiquitin/*metabolism | 2 | 1.0 |
NIH 3T3 Cells | 3 | 1.0 |
Biotinylation | 2 | 1.0 |
Two-Hybrid System Techniques | 3 | 0.0 |
Saccharomyces cerevisiae/genetics/growth & development/metabolism | 2 | 25.0 |
Saccharomyces cerevisiae Proteins/genetics/*metabolism | 2 | 5.0 |
Mice, Knockout | 2 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Saccharomyces cerevisiae Proteins/metabolism | 2 | 6.0 |
Saccharomyces cerevisiae Proteins/*metabolism | 3 | 14.0 |
*Mutation | 2 | 0.0 |
